Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice

Drug Design, Development and Therapy

Volumn 9, Issue , 2015, Pages 3923-3934

  Pandurangan, Ashok Kumar ^a,b   Mohebali, Nooshin ^b   Norhaizan, Mohd Esa ^a   Looi, Chung Yeng ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Enzymic antioxidants; IL 21; MDA; NQO1; Nrf2

Indexed keywords

CATALASE; DEXTRAN SULFATE; GALLIC ACID; GLUCURONOSYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 21; INTERLEUKIN 23; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GASTROINTESTINAL AGENT; INTERLEUKIN DERIVATIVE; MESSENGER RNA; NFE2L2 PROTEIN, MOUSE; NQO1 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UDP-GLUCURONOSYLTRANSFERASE 1A9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; COLON WEIGHT LENGTH RATIO; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY SCORE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; GENE; GENE EXPRESSION; HEMATOCRIT; HISTOPATHOLOGY; IL 21 GENE; IL 23 GENE; INTESTINE PARAMETERS; INTESTINE ULCER; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; NQO1 GENE; NUCLEAR LOCALIZATION SIGNAL; OXIDATION REDUCTION STATE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UDP GT GENE; ULCERATIVE COLITIS; UPREGULATION; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; COLITIS; COLON; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; COLITIS; COLON; CYTOPROTECTION; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GALLIC ACID; GASTROINTESTINAL AGENTS; GENE EXPRESSION REGULATION; GLUCURONOSYLTRANSFERASE; INTERLEUKIN-23; INTERLEUKINS; MALE; MICE, INBRED BALB C; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RNA, MESSENGER;

EID: 84938365587     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S86345     Document Type: Article

References (59)

1. Abraham C, Cho JH. Inflammatory bowel disease. New Eng J Med. 2009;361:2066–2078.
2. Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs. 2005;65:2253–2286.
3. Holma R, Salmenperä P, Virtanen I, Vapaatalo H, Korpela R. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats. J Physiol Pharmacol. 2007;58:455–467.
4. Tokoi S, Ohkusa T, Okayasu I, Nakamura K. Population changes in immunoglobulin-containing mononuclear cells in dextran sulfate sodium-induced colitis. J Gastroenterol. 1996;31:182–188.
5. Damiani CR, Benetton CA, Stoffel C, et al. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium. J Gastroenterol Hepatol. 2007;22:1846–1851.
6. Kruidenier L, Verpaget HW. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Aliment Pharmacol Ther. 2002;16:1997–2015.
7. Pavlick KP, Laroux FS, Fuseler J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med. 2002;33:311–322.
8. Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol. 2005;11:2371–2384.
9. Ran ZH, Chen C, Xiao SD. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother. 2008;62:189–196.
10. Amrouche-Mekkioui I, Djerdjouri B. N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice. Eur J Pharmacol. 2012;691:209–217.
11. Dinkova-Kostova AT, Holtzclaw WD, Kensler TW. The role of Keap1 in cellular protective responses. Chem Res Toxicol. 2005;18:1779–1791.
12. Furukawa M, Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol. 2005;25:162–171.
13. Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 2005;7:385–394.
14. Motohashi H, Katsuoka F, Engel JD, Yamamoto M. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc Natl Acad Sci U S A. 2004;101:6379–6384.
15. Osburn WO, Wakabayashi N, Misra V, et al. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys. 2006;454:7–15.
16. Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, Ganapasam S. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through Nrf2 signaling. Toxicol Mech Methods. 2014;24(1):13–20.
17. Ma J, Luo XD, Protiva P, et al. Bioactive novel polyphenols from the fruit of Manilkara zapota (Sapodilla). J Nat Prod. 2003;7:983–986.
18. Singh J, Rai GK, Upadhyay AK, Kumar R, Singh KP. Antioxidant phytochemicals in tomato (Lycopersicon esculentum). Indian Journal of Agricultural Science. 2004;74:3–5.
19. Shahrzad S, Bitsch I. Determination of some pharmacologically active phenolic acids in juices by high-performance liquid chromatography. J Chromatogr A. 1996;741(2):223–231.
20. Subramanian V, Venkatesan B, Tumala A, Vellaichamy E. Topical application of Gallic acid suppresses the 7,12-DMBA/Croton oil induced two-step skin carcinogenesis by modulating anti-oxidants and MMP-2/MMP-9 in Swiss albino mice. Food Chem Toxicol. 2014;66:44–55.
21. Lee DS, Je JY. Gallic acid-grafted-chitosan inhibits foodborne pathogens by a membrane damage mechanism. J Agric Food Chem. 2013;61(26):6574–6579.
22. Daduang J, Palasap A, Daduang S, Boonsiri P, Suwannalert P, Limpaiboon T. Gallic acid enhancement of gold nanoparticle anticancer activity in cervical cancer cells. Asian Pac J Cancer Prev. 2015;16(1):169–174.
23. Kroes BH, van den Berg AJ, Quarles van Ufford HC, van Dijk H, Labadie RP. Anti-inflammatory activity of gallic acid. Planta Med. 1992;58:499–504.
24. Ho HH, Chang CS, Ho WC, Liao SY, Lin WL, Wang CJ. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Toxicol Appl Pharmacol. 2013;266(1):76–85.
25. Ji BC, Hsu WH, Yang JS, et al. Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo. J Agric Food Chem. 2009;57(16):7596–7604.
26. Ito R, Kita M, Shin-Ya M, et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun. 2008;377:12–16.
27. Ito R, Shin-Ya M, Kishida T, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol. 2006;146:330–338.
28. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358.
29. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys. 1984;21:130–132.
30. Sinha KA. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–394.
31. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484–490.
32. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–590.
33. Pandurangan AK, Ismail S, Saadatdoust Z, Esa NM. Allicin Alleviates Dextran Sodium Sulfate-(DSS-) Induced Ulcerative Colitis in BALB/c Mice. Oxid Med Cell Longevity. 2015;2015:605208.
34. Pandurangan AK, Saadatdoust Z, Esa NM, Hamzah H, Ismail A. Dietary Cocoa protects against colitis-associated cancer by activating Nrf2/Keap1 pathway. Biofactors. 2015;41(1):1–14.
35. Ashokkumar P, Sudhandiran G. Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/β-catenin pathway. Invest New Drugs. 2011;29(2):273–284.
36. Pandurangan AK, Esa NM. Signal transducer and activator of transcription 3 – a promising target in colitis-associated cancer. Asian Pac J Cancer Prev. 2014;15(2):551–560.
37. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterol. 2001;121:255–260.
38. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–1625.
39. Sultan K, Korelitz BI, Present D, Katz S, Sunday S, Shapira I. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:1855–1858.
40. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57–79.
41. Sarra M, Pallone F, Monteleone G. Interleukin-21 in chronic inflammatory diseases. Biofactors. 2013;39(4):368–373.
42. Jauch D, Martin M, Schiechl G, et al. Interleukin 21 controls tumor growth and tumor immunosurveillance in colitis-associated tumorigenesis in mice. Gut. 2011;60:1678–1686.
43. Fina D, Sarra M, Caruso R, et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut. 2008;57:887–892.
44. Monteleone G, Monteleone I, Fina D, et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn’s disease. Gastroenterol. 2005;128:687–694.
45. Rovedatti L, Kudo T, Biancheri P, et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut. 2009;58:1629–1636.
46. McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut. 2007;56(10):1333–1336.
47. Schmidt C, Giese T, Ludwig B, et al. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn’s disease but not in ulcerative colitis. Inflamm Bowel Dis. 2005;11:16–23.
48. Camuesco D, Rodríguez-Cabezas ME, Garrido-Mesa N, et al. The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis. Br J Pharmacol. 2012;165:729–740.
49. Liu Z, Yadav PK, Xu X, et al. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol. 2011;89:597–606.
50. Xu L, Yang ZL, Li P, Zhou YQ. Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine. 2009;16:989–995.
51. Lee IA, Park YJ, Yeo HK, Han MJ, Kim DH. Soyasaponin I attenuates TNBS-induced colitis in mice by inhibiting NF-κB pathway. J Agric Food Chem. 2010;58:10929–10934.
52. Rieder F, Brenmoehl J, Leeb S, Schölmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut. 2007;56:130–139.
53. Ashokkumar P, Sudhandiran G. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharmacother. 2008;62:590–597.
54. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys. 1990;280(1):1–8.
55. Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711–760.
56. Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN. Nrf2-defcient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 2006;66(24):11580–11584.
57. Osburn WO, Karim B, Dolan PM, et al. Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer. 2007;121:1883–1891.
58. Trivedi PP, Jena GB. Role of α-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis. Food Chem Toxicol. 2013;59:339–355.
59. Khor TO, Huang MT, Prawan A, et al. Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res (Phila). 2008;1(3):187–191.